510(k) Report

510(k) · Cleared

Cleared

NBM-200MP Pulse Oximetry Device

K091564510(k) TraditionalCleared Mar 19, 2010295-day reviewClass II21 CFR 870.2700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Orsense, Ltd. · DQA Oximeter

Cleared on Mar 19, 2010 as substantially equivalent to K053269 (Masimo Corporation, 2005) and 2 other predicates after a 295-day review. Its family tree reaches back 4 generations to 2000. 2 later devices descend from it.

Decided
Mar 19, 2010
Review
295 days
Class
Class II
Product code
DQA
Recalls
None
Predicates
3

Its longest line of descent runs back 4 generations to K000126 (2000). 11 ancestors in all, the oldest K822055 (1982). 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2007: 1 other ancestor1992: 1 other ancestor2003: 1 other ancestor2002: 1 other ancestor1988: 1 other ancestor1982: 1 other ancestor2000: 1 other ancestor2013: 1 descendant cleared2015: 1 descendant clearedK000126 · Masimo Set Radical Pulse Oximeter with Satshare, Masimo Lnop-Adt-Adult/Pediatric Disposable Sensor, Masimo Lno-PDT-Pedia · Masimo Corp. · 2000K031330 · Modification to Masimo Set Radical Pulse Oximeter with Satshare and Lnop Series of Sensors and Cables · Masimo Corp. · 2003K033296 · Masimo Set Rad-5 Pulse Oximeter, Model Rad-5; Masimo Set Rad-5V Pulse Oximeter, Model Rad-5V · Masimo Corp. · 2004 · recalledK053269 · Masimo Set Rad-8 Pulse Oximeter · Masimo Corporation · 200519801990200020102020
  1. Root · 4 generations backK000126 Masimo Set Radical Pulse Oximeter with Satshare, Masimo…Masimo Corp. · 2000
  2. 3 generations backK031330 Modification to Masimo Set Radical Pulse Oximeter with Satshare and…Masimo Corp. · 2003
  3. 2 generations backK033296 Masimo Set Rad-5 Pulse Oximeter, Model Rad-5; Masimo Set Rad-5V…Masimo Corp. · 2004 · Recalled
  4. 1 generation backK053269 Masimo Set Rad-8 Pulse OximeterMasimo Corporation · 2005
  5. This deviceK091564 NBM-200MP Pulse Oximetry DeviceOrsense, Ltd. · 2010
  6. Descendant · cites it directly · 1 of its ownK124041 NBM-200MPOrsense, Ltd. · 2013
  7. Descendant · 2 generations on · 0 of its ownK142209 Pulse oximeter NBM-200Orsense, Ltd. · 2015

Most influential descendants

Showing 2 of 2 · See all
  • K124041NBM-200MPOrsense, Ltd. · 2013 · cites it directly1descendant
  • K142209Pulse oximeter NBM-200Orsense, Ltd. · 2015 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K000126Masimo Set Radical Pulse Oximeter with Satshare, Masimo…Masimo Corp.2000—
−3K031330Modification to Masimo Set Radical Pulse Oximeter with Satshare and Lnop…Masimo Corp.2003—
−2K033296Masimo Set Rad-5 Pulse Oximeter, Model Rad-5; Masimo Set Rad-5V Pulse…Masimo Corp.20041
−1K053269Masimo Set Rad-8 Pulse OximeterMasimo Corporation2005—
0 (this device)K091564NBM-200MP Pulse Oximetry DeviceOrsense, Ltd.2010—
+1K124041NBM-200MPOrsense, Ltd.2013—
+2K142209Pulse oximeter NBM-200Orsense, Ltd.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198210
198810
199210
200010
200210
200310
200710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201510
FIG. 1 — Lineage of K091564, 2000–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQA device

  1. #1 K221282 Empatica Health Monitoring Platformscore 20.1 · 38 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053269Masimo Set Rad-8 Pulse Oximeter
Summary page 2
…OrSense 510O(k) -SET Rad-8 Pulse Oximeter (K053269) manufactured by Masimo corp. SET Rad-8 is a pulse oximeter device, similar to the NBM-…
Masimo Corporation2005—
*K910077Crit-Scan
Summary page 2
…corp. SET Rad-8 is a pulse oximeter device, similar to the NBM- 200MP pulse oximeter device. -CHIT-SCAN (K910077) manufactured by In-Line Diagnostics. CRIT-SCAN is a non-invasive hemnatocrit measuring device,…
Noninvasive Medical Technology Corp.1992—
*K072049Continuous Non-Invasive Cardiac Output and Blood Pressure Monitor with Real-Time…
Summary page 2
…s also using a pnieumatic cuff technology for temporary inflation and deflation around a finger. -BMEYE NEXFLNHD (K072049) manufactured by BMEYE B.V. (The Netherlands). BMEYE NEXFIN_HD is a non-invasive mo…
Bmeye B.V.2007—

Also cleared against K053269: 4 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K124041NBM-200MPOrsense, Ltd.20131

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 3.1 years on median.
  • 2 of the 11 ancestors have a recall of any class.
  • Of its descendants, K124041 (Orsense, Ltd., 2013) has gone furthest, with 1 descendant of its own.
  • 4 other devices also cite its predicate K053269.

How does its category compare?

All DQA devices

DQA Oximeter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DQA

15in 2025

2007: 202008: 222009: 352010: 292011: 152012: 142013: 152014: 112015: 132016: 142017: 92018: 182019: 192020: 152021: 102022: 202023: 132024: 142025: 152026 (partial year): 8
2007high 35 (2009) · low 9 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQA

182in 2025

2007: 122 days median2008: 97 days median2009: 117 days median2010: 127 days median2011: 195 days median2012: 120 days median2013: 182 days median2014: 175 days median2015: 158 days median2016: 246 days median2017: 200 days median2018: 260 days median2019: 158 days median2020: 126 days median2021: 174 days median2022: 265 days median2023: 317 days median2024: 285 days median2025: 182 days median2026 (partial year): 187 days median
2007high 317 (2023) · low 97 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQA

3in 2024

2007: 62008: 52009: 292010: 42011: 12014: 22015: 12018: 322024: 3
2007high 32 (2018) · low 0 (2012)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DQA

399in 2025

2007: 3252008: 3122009: 2812010: 1852011: 1642012: 3222013: 4682014: 1,1242015: 2,0822016: 1,7752017: 1,1902018: 6942019: 5482020: 4262021: 5532022: 4782023: 3922024: 5452025: 399
2007high 2,082 (2015) · low 164 (2011)2025

MAUDE reports naming product code DQA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007201226325
200822975312
20093511729281
2010291274185
2011151951164
2012141200322
2013151820468
20141117521,124
20151315812,082
20161424601,775
2017920001,190
20181826032694
2019191580548
2020151260426
2021101740553
2022202650478
2023133170392
2024142853545
2025151820399
202681870—

What is it indicated for?

The NMB-200MP is a portable Oximetry monitor which may be used in low perfusion conditions. It non-invasively and continuously monitors and displays arterial blood oxygen saturation (SpO2), temporary occluded arterial blood oxygen saturation (SoO2), pulse rate (P.R.) and plethysmogram waveform. Temporary occluded arterial blood oxygen saturation (SoO2) is intended for use under any conditions that will cause poor signal quality. It is not intended for…

Read the full statement (110 words)

The NMB-200MP is a portable Oximetry monitor which may be used in low perfusion conditions. It non-invasively and continuously monitors and displays arterial blood oxygen saturation (SpO2), temporary occluded arterial blood oxygen saturation (SoO2), pulse rate (P.R.) and plethysmogram waveform.

Temporary occluded arterial blood oxygen saturation (SoO2) is intended for use under any conditions that will cause poor signal quality. It is not intended for use under motion conditions.

It may be used on adult patients in the hospital or clinical environments.

The NBM-200MP permits continuous patient monitoring with adjustable alarm limits for oximetry, as well as visible and audible alarm signals.

The NBM-200MP is NOT intended for home use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K091564: NBM-200MP Pulse Oximetry Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K091564

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026